Trials / Withdrawn
WithdrawnNCT03333759
Treatment of Acne Scars With Erbium:Yttrium Aluminum Garnet (Er:YAG) Laser Examined Under OCT
Treatment of Atrophic Facial Acne Scars With Er:YAG Laser Examined Under Optical Coherence Tomography
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- University of Miami · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Accepted
Summary
This study is examining the effects of the 2940 nm Er:YAG on atrophic facial acne scars under optical coherence tomography in terms of blood flow, vessel shape, skin roughness, collagen content, and epidermal thickness.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Alma - Harmony XL Laser | The Erbium YAG laser at a 2940nm wavelength is used for ablative laser resurfacing as well as treating acne scars. |
Timeline
- Start date
- 2018-08-01
- Primary completion
- 2018-12-01
- Completion
- 2018-12-01
- First posted
- 2017-11-07
- Last updated
- 2018-07-26
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03333759. Inclusion in this directory is not an endorsement.